Hospital
Elkhart General Hospital, INC.
Elkhart General Hospital, INC. was paid $25.59M by Medicaid between Jan 2018 and Nov 2024, across 120 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoELKHART GENERAL HOSPITAL, INC.
ELKHART, IN 46514
ELKHART, IN 46514
33aNPI1477551489assigned 07/13/2005
33bProvider typePsychiatric Hospital Unit
28Total paid$25.59M
24GClaims447,450
24DCodes billed120
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Indiana
Rank by total paid#3 of 5
Median peer was paid$25.59M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official COSTELLO, JEFFREY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 58,034 | $1.67M | |
| 2019 | 56,808 | $2.69M | |
| 2020 | 53,237 | $2.91M | |
| 2021 | 67,537 | $4.21M | |
| 2022 | 79,229 | $5.34M | |
| 2023 | 76,979 | $5.10M | |
| 2024incomplete | 55,626 | $3.68M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 62,382 | 55,771 | $9.03M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 34,453 | 29,140 | $4.66M |
| 71045 | Radiologic examination, chest; single view | 9.5% | 20,984 | 17,659 | $2.44M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.4% | 9,195 | 7,657 | $1.37M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5.3% | 24,409 | 19,998 | $1.36M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.4% | 9,225 | 8,475 | $1.12M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3.6% | 1,695 | 729 | $910K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.6% | 376 | 323 | $674K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 1,869 | 1,567 | $555K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.1% | 8,195 | 6,946 | $537K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.9% | 4,713 | 4,357 | $496K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 3,790 | 3,430 | $300K |
108 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 58,548 | $213K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,892 | $191K |
| 80053 | Comprehensive metabolic panel | <1% | 34,726 | $178K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 12,258 | $176K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,480 | $116K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,364 | $95K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 84 | $92K |
| 30140 | <1% | 108 | $83K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 67 | $82K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,044 | $64K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 315 | $64K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,867 | $59K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,708 | $58K |
| 81001 | <1% | 34,849 | $55K | |
| 84484 | <1% | 5,661 | $51K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,494 | $51K |
| 62323 | <1% | 49 | $46K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,794 | $36K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 555 | $36K |
| 87631 | <1% | 638 | $32K | |
| 81025 | <1% | 5,951 | $26K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $26K |
| 83880 | <1% | 1,396 | $24K | |
| 83735 | <1% | 7,102 | $22K | |
| 83690 | <1% | 7,389 | $21K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 106 | $19K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 560 | $18K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 135 | $16K |
| 11043 | <1% | 30 | $15K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 616 | $15K |
| 74018 | <1% | 133 | $14K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 803 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 987 | $10K |
| 82077 | <1% | 1,046 | $10K | |
| 99221 | <1% | 29 | $10K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 135 | $9K |
| 64493 | <1% | 19 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 982 | $7K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 17 | $7K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 22 | $7K |
| 85730 | <1% | 2,736 | $6K | |
| 84703 | <1% | 1,294 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 54 | $5K |
| 85610 | <1% | 2,912 | $5K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 347 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 411 | $4K |
| 64494 | <1% | 19 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 229 | $4K |
| 11045 | <1% | 27 | $3K | |
| 83605 | <1% | 538 | $3K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 22 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 15 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 641 | $2K |
| 93017 | <1% | 23 | $1K | |
| 80076 | <1% | 240 | $1K | |
| 80143 | <1% | 110 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 241 | $1K |
| 80179 | <1% | 94 | $1K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 33 | $913.92 |
| 85027 | <1% | 265 | $858.09 | |
| 87040 | <1% | 72 | $621.40 | |
| 82948 | <1% | 190 | $607.15 | |
| 73130 | <1% | 12 | $595.40 | |
| 87807 | <1% | 115 | $565.67 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 45 | $528.60 |
| 85379 | <1% | 72 | $459.01 | |
| 73630 | <1% | 26 | $381.23 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $306.77 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $306.77 |
| 87081 | <1% | 120 | $259.66 | |
| 96367 | <1% | 22 | $221.13 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $201.60 |
| 84702 | <1% | 13 | $116.97 | |
| 82950 | <1% | 56 | $106.66 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 23 | $104.10 |
| 80306 | <1% | 18 | $52.26 | |
| 82150 | <1% | 30 | $51.20 | |
| 81003 | <1% | 82 | $41.75 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,271 | $39.15 |
| 86850 | <1% | 13 | $15.63 | |
| 80069 | <1% | 16 | $10.40 | |
| 86900 | <1% | 13 | $8.97 | |
| 86901 | <1% | 13 | $8.97 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,764 | $4.84 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 148 | $4.66 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 452 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 45 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 292 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 184 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 19 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 108 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 71 | $0.00 |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 0% | 16 | $0.00 |
| 90715 | 0% | 15 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 4,510 | $0.00 |
| 36591 | 0% | 865 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 1,152 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 600 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 821 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 86 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 484 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 67 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 493 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 280 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 146 | $0.00 |
| 88304 | 0% | 13 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 25 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOSTELLO, JEFFREY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Memorial Hospital of South Bend | South Bend, IN | $33.19M |
| Beacon Medical Group, INC. | Granger, IN | $7.19M |
| Beacon Medical Group, INC. | South Bend, IN | $4.76M |
| Beacon Medical Group, INC. | South Bend, IN | $4.65M |
| Beacon Medical Group, INC. | Elkhart, IN | $4.64M |
| Beacon Medical Group, INC. | South Bend, IN | $4.44M |
| Beacon Medical Group, INC. | La Porte, IN | $3.38M |
| Beacon Medical Group, INC. | Elkhart, IN | $2.45M |
| Beacon Medical Group, INC. | Granger, IN | $2.11M |
| Beacon Medical Group, INC. | South Bend, IN | $1.53M |
| Memorial Hospital of South Bend | Granger, IN | $1.34M |
| Beacon Medical Group, INC. | South Bend, IN | $1.09M |
| Beacon Medical Group, INC. | South Bend, IN | $1.07M |
| Beacon Medical Group, INC. | Elkhart, IN | $953K |
| Beacon Medical Group, INC. | South Bend, IN | $872K |
| Beacon Medical Group, INC. | Mishawaka, IN | $836K |
| Beacon Medical Group, INC. | Elkhart, IN | $758K |
| Beacon Health, LLC | Granger, IN | $733K |
| Beacon Medical Group, INC. | Mishawaka, IN | $727K |
| Beacon Medical Group, INC. | Bristol, IN | $725K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.